THE POTENTIAL FOR ADDED BENEFITS WITH BETA-BLOCKERS AND CALCIUM-ANTAGONISTS IN TREATING CARDIOVASCULAR DISORDERS

被引：16

作者：

NAYLER, WG ^{[1
]}

机构：

[1] UNIV MELBOURNE,DEPT MED,PARKVILLE,VIC 3052,AUSTRALIA

来源：

DRUGS | 1988年 / 35卷

关键词：

D O I：

10.2165/00003495-198800354-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1 / 8

页数：8

共 26 条

[1] INHIBITION OF HUMAN-PLATELET FUNCTION BY VERAPAMIL [J].

ADDONIZIO, VP ;

FISHER, CA ;

STRAUSS, JF ;

EDMUNDS, LH .

THROMBOSIS RESEARCH, 1982, 28 (04) :545-556

[2]

[Anonymous], 1986, Lancet, V2, P57

[3] EFFECTS OF PROPRANOLOL ON ATHEROGENESIS IN THE CHOLESTEROL-FED RABBIT [J].

CHOBANIAN, AV ;

BRECHER, P ;

CHAN, C .

CIRCULATION RESEARCH, 1985, 56 (05) :755-762

[4] [H-3] VERAPAMIL BINDING TO RAT CARDIAC SARCOLEMMAL MEMBRANE-FRAGMENTS - AN EFFECT OF ISCHEMIA [J].

DILLON, JS ;

NAYLER, WG .

BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (01) :99-109

[5] SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].

FLECKENSTEIN, A .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166

[6] DILTIAZEM AND REINFARCTION IN PATIENTS WITH NON-Q-WAVE MYOCARDIAL-INFARCTION - RESULTS OF A DOUBLE-BLIND, RANDOMIZED, MULTICENTER TRIAL [J].

GIBSON, RS ;

BODEN, WE ;

THEROUX, P ;

STRAUSS, HD ;

PRATT, CM ;

GHEORGHIADE, M ;

CAPONE, RJ ;

CRAWFORD, MH ;

SCHLANT, RC ;

KLEIGER, RE ;

YOUNG, PM ;

SCHECHTMAN, K ;

PERRYMAN, MB ;

ROBERTS, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (07) :423-429

[7] ATHEROSCLEROSIS, CALCIUM, AND CALCIUM-ANTAGONISTS [J].

HENRY, PD .

CIRCULATION, 1985, 72 (03) :456-459

[8]

HJALMARSON A, 1983, CIRCULATION, V67, P26

[9]

HUGENHOLTZ PG, 1985, HDB EXPT PHARM, V76, P459

[10] 1,4-DIHYDROPYRIDINE CA-2+ CHANNEL ANTAGONISTS AND ACTIVATORS - A COMPARISON OF BINDING CHARACTERISTICS WITH PHARMACOLOGY [J].

JANIS, RA ;

TRIGGLE, DJ .

DRUG DEVELOPMENT RESEARCH, 1984, 4 (03) :257-274

← 1 2 3 →